Declaring an attempt at negotiating a voluntary licence under Canada's Access to Medicines Regime
The pharmaceutical company must complete and submit to the Commissioner of Patents a Solemn or Statutory Declaration Under Paragraph 21.04(3)(c) of the Patent Act. The form sets out the information that must appear in the declaration.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2020-09-17
Data overview
- Formats
- HTML
- File languages
- English, French